In this study, we investigated the role of CRAM in B-CLL, analysing CCL19 induced activation and found that CRAM is an efficient modulator of CCR7-CCL19 cellular responses. This evidence concerns the gene CCRL2 and B-cell chronic lymphocytic leukemia.